Table_1_Colchicine Effectiveness and Safety in Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenitis.pdf by Tatjana Welzel (11753417)

“…Colchicine was started at 0.5–1.0 mg/day. DA was captured by physician (PGA) and patient/parent (PPGA) global assessment on a 10 cm visual analog scale, categorized as mild (<2), moderate (2–4), and high (≥5). …”

The CCDC66 depletion disrupts endocytosis and membrane recycling near cilia. by Jovana Deretic (13113617)

“…<b>(B)</b> Measured is the mean pixel intensity of a circular 5 μm² area centered at the ciliary base of each cell in <b>(A)</b>. …”

Clinical and Imaging Characteristics of Posterior Scleritis in Children by Ayala Katzir (20605679)

“…Initial echography showed increased posterior scleral thickness (mean±SD 2.9 ± 0.68 mm) with a significant reduction four ± 2 months later (mean±SD 1.85 ± 0.62 mm). …”

AS101 prevents renal hypertrophy in STZ injected rats. by Itay Israel Shemesh (669254)

“…*p<0.01 increase vs. control group. #p<0.01 decrease vs. STZ+PBS group (n = 5 for Control; n = 7 for STZ+PBS; n = 9 for STZ+AS101 LD; n = 8 for STZ+AS101 HD).…”

Effects of CANA on metabolites evaluated by metabolomics. by Dan Nakano (8775380)

“…Red circle indicates differential metabolites, which determined the condition of >1.5-fold increase with P<0.05 or <0.7-fold decrease with P<0.05. …”

Effectiveness of all intervention scenarios. by Yae Jee Baek (9565342)

“…We assume the sensitivity of front door screening of 0.5 or 0.7 and the protection rates possibly becoming 0.3, 0.6, or 0.9 as reinforcing protection device. …”

Effectiveness of all intervention scenarios. by Yae Jee Baek (9565342)

“…We assume the sensitivity of front door screening of 0.5 or 0.7 and the protection rates possibly becoming 0.3, 0.6, or 0.9 as reinforcing protection device. …”

Figure 2. Deletion of Arrb1 attenuates the VEGF-C/VEGFR3 signaling in mice exposed to hypoxia. by Zhiyuan Ma (6441500)

Effect of siRNA specific for PIASy and E12 in α-SMA regulation in MCs. by Kazuo Torikoshi (150022)

“…<p>(A) PIASy mRNA and protein were reduced by transfection of siRNA against PIASy in mouse MCs. …”

Data_Sheet_1_Molecular epidemiological characteristics of Mycobacterium leprae in highly endemic areas of China during the COVID-19 epidemic.docx by Jiaojiao Zhou (432827)

“…</p>Results<p>There was an 18.97% decrease in the number of counties and districts reporting cases. …”

¹H NMR in Solution and Solid State Structural Study of Lanthanide(III) Cryptates by C. Platas (2978436)

“…We present here a detailed structural comparison, both in the solid state and in aqueous solution, of a complete series of lanthanide cryptate complexes of a Schiff base axial macrobicyclic ligand L of general formula [LnL][NO₃]₃·<i>x</i>H₂O (Ln = La−Lu, Y); the macrobicyclic receptor L is an azacryptand N[(CH₂)₂NCH−R−CHN(CH₂)₂]₃N (R = <i>m</i>-C₆H₂OH-2-Me-5). …”

DataSheet_1_Nationwide Trends of Pediatric Obesity and BMI z-Score From 2017-2021 in China: Comparable Findings From Real-World Mobile- and Hospital-Based Data.docx by Yan Yang (33204)

“…The trend of obesity prevalence remained stable with slight decrease, but COVID-19 lockdown caused a significant increase of 1.86% in 2020. …”

Mutations at p53 binding sites augment PIK3CA promoter activity. by Snehal M. Gaikwad (279479)

“…Representative bioluminescent images of the mice bearing tumors of A2780-MPFT3 cells. Mouse from control and treated group exhibited specific [Fig. 5e3 (pre-treatment)] signals which did not decrease even after two treatments of cisplatin [Fig. 5e3 (post-treatment)].…”

Model schematics. by Gergely Boza (298386)

“…<p>(<b>a</b>) We model two strain types, parasitic (violet shading) and antibiotic-producer (blue shading), which compete with each other directly (grey arrow), and indirectly via the diffusing antibiotic (red dots and coloured arrows). …”

Table1_Effect of botanical drugs in improving symptoms of hypertensive nephropathy: Analysis of real-world data, retrospective cohort, network, and experimental assessment.XLSX by Jia-Ming Huan (15185389)

“…</p><p>Results: A total of 14 botanical drugs and five symptom communities were obtained from real-world clinical data. …”

Image_1_Cardioprotecive Properties of Known Agents in Rat Ischemia-Reperfusion Model Under Clinically Relevant Conditions: Only the NAD Precursor Nicotinamide Riboside Reduces Infa... by Yang Xiao (146335)

“…., opiates, benzodiazepines, P2Y₁₂ antagonist, propofol) need to be identified in preclinical models.</p><p>Methods: Here, we examined the efficacy of promising cardioprotective compounds [fingolimod (Fingo), empagliflozin (Empa), melatonin (Mela) and nicotinamide riboside (NR)] administered i.v. as bolus before start ischemia. …”

Effects of siRNA on RET/PTC3 Junction Oncogene in Papillary Thyroid Carcinoma: From Molecular and Cellular Studies to Preclinical Investigations by Hafiz Muhammad Ali (554920)

“…Our aim is to demonstrate <i>in vitro</i> and <i>in vivo</i> molecular and cellular effects of siRNA on <i>RET/PTC3</i> knockdown for therapeutic application.First, we established a novel cell line stably expressing <i>RET/PTC3</i> junction oncogene, named RP3 which was found tumorigenic in nude mice compared to NIH/3T3 mouse fibroblasts. …”

Data_Sheet_1_Cardioprotecive Properties of Known Agents in Rat Ischemia-Reperfusion Model Under Clinically Relevant Conditions: Only the NAD Precursor Nicotinamide Riboside Reduces... by Yang Xiao (146335)

“…., opiates, benzodiazepines, P2Y₁₂ antagonist, propofol) need to be identified in preclinical models.</p><p>Methods: Here, we examined the efficacy of promising cardioprotective compounds [fingolimod (Fingo), empagliflozin (Empa), melatonin (Mela) and nicotinamide riboside (NR)] administered i.v. as bolus before start ischemia. …”

Insights into the mechanism regulating the differential expression of the P28-OMP outer membrane proteins in obligatory intracellular pathogen <i>Ehrlichia chaffeensis</i> by Nan Duan (4837896)

Presentation 1_Telehealth coaching in older adults, behavior change, and impacts of the COVID-19 pandemic: analyses from The Brain Health Champion Study.pdf by Brittany McFeeley (21104825)

“…Study 1.0 participants indicated a decrease in cognitive activities since the start of COVID-19 restrictions, whereas those in Study 2.0 reported an increase in cognitive activities.…”